News &amp; Updates

At least 25 million individuals around the world are expected to live with Parkinson’s disease (PD) by the year 2050, posing a substantial public health challenge not just for patients and their families, but for caregivers, communities, and society as well, according to a study.

25M people seen to live with Parkinson’s disease in 2050

03 Apr 2025

Ganciclovir/valganciclovir tied to adverse effects in preterm infants with CMV

Preterm and very low birthweight (VLBW) infants who have been treated with ganciclovir (GCV) or oral valganciclovir (valGCV) for cytomegalovirus (CMV) disease are more likely to experience adverse events than term infants, a study has shown.

Ganciclovir/valganciclovir tied to adverse effects in preterm infants with CMV

EGFR gene mutation abundance predicts survival in NSCLC patients

In patients with nonsmall cell lung cancer (NSCLC), plasma epidermal growth factor receptor (EGFR) mutation abundance shows a significant association with survival benefit, reveals a study.

EGFR gene mutation abundance predicts survival in NSCLC patients

Delayed motherhood poses thyroid cancer risk

Women who gave birth to their first child at an older age face an increased risk of thyroid cancer development, according to an analysis of Asian cohort studies.

Delayed motherhood poses thyroid cancer risk

Penicillin allergy delabelled in 90 percent of patients after evaluation

Research from Queen Mary Hospital in Hong Kong shows that 90 percent of patients with suspected penicillin allergy were delabelled after undergoing Prospective Assessment of Penicillin Allergy (PAPA), and one in six of them received penicillins safely ≥6 months later.

Penicillin allergy delabelled in 90 percent of patients after evaluation

Zero HIV acquisition, high persistence through 1 year with cabotegravir LA as PrEP for MSM, transgender men

“Zero HIV acquisition” is a milestone that cabotegravir LA as PrEP has realized in the PILLAR real-world trial, along with high persistence observed through 12 months among 201 MSM and transgender men

Zero HIV acquisition, high persistence through 1 year with cabotegravir LA as PrEP for MSM, transgender men

Roughly half of diagnosed depression cases deemed treatment-resistant

02 Apr 2025 by

A considerable number of individuals who have received a diagnosis of major depressive disorder show little to no improvement despite having tried multiple antidepressant medications, according to new research.

Roughly half of diagnosed depression cases deemed treatment-resistant

02 Apr 2025

Cetuximab linked to pocket infections after central venous port placement

Cetuximab therapy appears to induce skin complications in patients following central venous port placement, reports a study.

Cetuximab linked to pocket infections after central venous port placement

Endocrinologic dysfunction common among CNS infection survivors

02 Apr 2025 by

Children who survived central nervous system (CNS) infections experience many endocrinologic imbalances, according to a study. Of these infections, meningitis poses the highest risk of subsequent endocrinopathies, particularly short stature.

Endocrinologic dysfunction common among CNS infection survivors

02 Apr 2025

Early-onset AD tied to higher risk of atopic march in children

Children with early-onset atopic dermatitis (AD) are at increased odds of developing atopic march conditions compared with those with early-onset AD, reveals a study.

Early-onset AD tied to higher risk of atopic march in children